Correlation Between Achilles Therapeutics and Coherus BioSciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Achilles Therapeutics and Coherus BioSciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Achilles Therapeutics and Coherus BioSciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Achilles Therapeutics PLC and Coherus BioSciences, you can compare the effects of market volatilities on Achilles Therapeutics and Coherus BioSciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Achilles Therapeutics with a short position of Coherus BioSciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Achilles Therapeutics and Coherus BioSciences.

Diversification Opportunities for Achilles Therapeutics and Coherus BioSciences

-0.77
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Achilles and Coherus is -0.77. Overlapping area represents the amount of risk that can be diversified away by holding Achilles Therapeutics PLC and Coherus BioSciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Coherus BioSciences and Achilles Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Achilles Therapeutics PLC are associated (or correlated) with Coherus BioSciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Coherus BioSciences has no effect on the direction of Achilles Therapeutics i.e., Achilles Therapeutics and Coherus BioSciences go up and down completely randomly.

Pair Corralation between Achilles Therapeutics and Coherus BioSciences

Given the investment horizon of 90 days Achilles Therapeutics is expected to generate 8.1 times less return on investment than Coherus BioSciences. But when comparing it to its historical volatility, Achilles Therapeutics PLC is 5.3 times less risky than Coherus BioSciences. It trades about 0.22 of its potential returns per unit of risk. Coherus BioSciences is currently generating about 0.34 of returns per unit of risk over similar time horizon. If you would invest  72.00  in Coherus BioSciences on August 29, 2024 and sell it today you would earn a total of  56.00  from holding Coherus BioSciences or generate 77.78% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Achilles Therapeutics PLC  vs.  Coherus BioSciences

 Performance 
       Timeline  
Achilles Therapeutics PLC 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Achilles Therapeutics PLC are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite quite weak technical indicators, Achilles Therapeutics disclosed solid returns over the last few months and may actually be approaching a breakup point.
Coherus BioSciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Coherus BioSciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Coherus BioSciences is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Achilles Therapeutics and Coherus BioSciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Achilles Therapeutics and Coherus BioSciences

The main advantage of trading using opposite Achilles Therapeutics and Coherus BioSciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Achilles Therapeutics position performs unexpectedly, Coherus BioSciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Coherus BioSciences will offset losses from the drop in Coherus BioSciences' long position.
The idea behind Achilles Therapeutics PLC and Coherus BioSciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Complementary Tools

Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon